MAPK3 and breast carcinoma: Enhanced pSmad3L through BLT1-Rac1/NOX4-EGFR-ERK1/2 linked signaling contributes to the resistance of MDA-MB231 breast cancer cells to the TGF-β1 growth-inhibitory response in vitro and in vivo